Jack Lee

Jack Lee is an accomplished professional with extensive experience in clinical and business development, particularly in the field of movement disorders. Currently serving as Chief Executive Officer at MDDT Inc, Jack has spearheaded clinical collaborations with pharmaceutical companies such as Allergan and Merz Pharma. As Senior Director of Capital Access at OBIO, Jack manages programs that support venture-backed life science companies. Previously, Jack held key roles at London Health Sciences Centre, overseeing clinical management of numerous trials, and was a co-founder of a medical device spinout affiliated with Western University. Jack's educational background includes a Master of Science in Physiology and Pharmacology and executive training at the Ivey Business School.